NLRP3 and early-onset autosomal dominant Alzheimer disease: Abnormal activation of NLRP3 inflammasomes can exacerbate inflammation-driven diseases, such as Cryopyrin-associated cyclical syndromes, Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, and cancer.